Republican Lawmaker Takes Unusual Step Of Attacking FDA Salaries Over Abortion Pill Decisions
Executive Summary
A move to cut senior FDA positions including CDER Director through the appropriations process is rare and almost certain to fail, but experts say the attempt is indicative of an environment that seems to be encouraging these personal amendments.
You may also be interested in...
Heritable Genetic Modification Debate May Ignite Again As Technology Advances
CBER Director Peter Marks said the US may have to consider whether to maintain its ban on the practice of creating embryos to include heritable genetic modifications if other countries allow the practice.
US FDA’s Standard Application Assessment Makes A Comeback
After years where many more applications received priority assessments than standard assessments, in FY 2022 the difference narrowed.
House FY 2024 Approps Bill Nixes US FDA Mifepristone REMS Changes, Cuts Funding
Tobacco rules limiting nicotine and banning menthol in cigarettes also would be defunded in the bill.